Bradley Foster & Sargent’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.3M | Buy |
678,377
+64,360
| +10% | +$1.68M | 0.23% | 94 |
|
|
2026
Q1 | $17.2M | Buy |
614,017
+13,128
| +2% | +$350K | 0.27% | 77 |
|
|
2025
Q4 | $15M | Buy |
600,889
+13,084
| +2% | +$330K | 0.22% | 86 |
|
|
2025
Q3 | $15M | Buy |
587,805
+65,206
| +12% | +$1.61M | 0.22% | 90 |
|
|
2025
Q2 | $12.7M | Buy |
522,599
+45,452
| +10% | +$1.06M | 0.2% | 98 |
|
|
2025
Q1 | $12.1M | Buy |
477,147
+53,917
| +13% | +$1.41M | 0.21% | 92 |
|
|
2024
Q4 | $11.2M | Buy |
423,230
+139,215
| +49% | +$3.78M | 0.19% | 103 |
|
|
2024
Q3 | $8.22M | Buy |
284,015
+12,895
| +5% | +$376K | 0.14% | 118 |
|
|
2024
Q2 | $7.59M | Buy |
271,120
+8,375
| +3% | +$231K | 0.14% | 119 |
|
|
2024
Q1 | $7.29M | Sell |
262,745
-19,926
| -7% | -$553K | 0.13% | 123 |
|
|
2023
Q4 | $8.14M | Sell |
282,671
-47,802
| -14% | -$1.45M | 0.16% | 110 |
|
|
2023
Q3 | $12.1M | Hold |
330,473
| – | – | 0.25% | 82 |
|
|
2023
Q2 | $12.1M | Buy |
330,473
+10,147
| +3% | +$395K | 0.25% | 82 |
|
|
2023
Q1 | $13.1M | Sell |
320,326
-18,678
| -6% | -$807K | 0.31% | 73 |
|
|
2022
Q4 | $17.4M | Sell |
339,004
-3,468
| -1% | -$166K | 0.44% | 61 |
|
|
2022
Q3 | $15M | Sell |
342,472
-3,089
| -0.9% | -$150K | 0.41% | 61 |
|
|
2022
Q2 | $18.1M | Buy |
345,561
+4,549
| +1% | +$232K | 0.47% | 58 |
|
|
2022
Q1 | $17.7M | Buy |
341,012
+28,226
| +9% | +$1.46M | 0.38% | 65 |
|
|
2021
Q4 | $18.5M | Buy |
312,786
+4,900
| +2% | +$243K | 0.38% | 67 |
|
|
2021
Q3 | $13.2M | Buy |
307,886
+390
| +0.1% | +$17.3K | 0.31% | 74 |
|
|
2021
Q2 | $12M | Sell |
307,496
-4,877
| -2% | -$190K | 0.28% | 78 |
|
|
2021
Q1 | $11.3M | Sell |
312,373
-44,619
| -12% | -$1.58M | 0.29% | 78 |
|
|
2020
Q4 | $13.1M | Sell |
356,992
-13,120
| -4% | -$481K | 0.35% | 72 |
|
|
2020
Q3 | $12.9M | Buy |
+370,112
| New | +$13M | 0.38% | 68 |
|
|
2020
Q1 | $11.6M | Sell |
374,552
-14,726
| -4% | -$502K | 0.46% | 62 |
|
|
2019
Q4 | $14.5M | Sell |
389,278
-2,695
| -0.7% | -$96K | 0.45% | 64 |
|
|
2019
Q3 | $13.4M | Sell |
391,973
-9,068
| -2% | -$330K | 0.45% | 66 |
|
|
2019
Q2 | $16.5M | Sell |
401,041
-13,283
| -3% | -$527K | 0.55% | 60 |
|
|
2019
Q1 | $16.7M | Sell |
414,324
-7,741
| -2% | -$310K | 0.58% | 56 |
|
|
2018
Q4 | $17.5M | Sell |
422,065
-114
| -0% | -$4.73K | 0.71% | 47 |
|
|
2018
Q3 | $17.7M | Buy |
422,179
+5,685
| +1% | +$219K | 0.6% | 51 |
|
|
2018
Q2 | $14.3M | Sell |
416,494
-1,256
| -0.3% | -$42.9K | 0.51% | 60 |
|
|
2018
Q1 | $14.1M | Buy |
417,750
+6,228
| +2% | +$214K | 0.53% | 58 |
|
|
2017
Q4 | $14.1M | Sell |
411,522
-3,342
| -0.8% | -$114K | 0.51% | 62 |
|
|
2017
Q3 | $14.1M | Buy |
414,864
+9,748
| +2% | +$313K | 0.54% | 62 |
|
|
2017
Q2 | $12.9M | Sell |
405,116
-6,405
| -2% | -$202K | 0.52% | 61 |
|
|
2017
Q1 | $13.4M | Sell |
411,521
-10,719
| -3% | -$338K | 0.54% | 60 |
|
|
2016
Q4 | $13M | Sell |
422,240
-12,499
| -3% | -$382K | 0.55% | 63 |
|
|
2016
Q3 | $14M | Sell |
434,739
-569
| -0.1% | -$19K | 0.61% | 61 |
|
|
2016
Q2 | $14.5M | Sell |
435,308
-2,107
| -0.5% | -$67.2K | 0.65% | 55 |
|
|
2016
Q1 | $12.3M | Buy |
437,415
+20,670
| +5% | +$590K | 0.57% | 58 |
|
|
2015
Q4 | $12.8M | Buy |
416,745
+8,319
| +2% | +$262K | 0.58% | 59 |
|
|
2015
Q3 | $12.2M | Buy |
408,426
+7,040
| +2% | +$226K | 0.6% | 56 |
|
|
2015
Q2 | $12.8M | Sell |
401,386
-7,340
| -2% | -$239K | 0.58% | 62 |
|
|
2015
Q1 | $13.5M | Buy |
408,726
+1,434
| +0.4% | +$45.6K | 0.62% | 56 |
|
|
2014
Q4 | $12M | Sell |
407,292
-2,799
| -0.7% | -$80.3K | 0.57% | 64 |
|
|
2014
Q3 | $11.5M | Buy |
410,091
+26,414
| +7% | +$741K | 0.55% | 67 |
|
|
2014
Q2 | $10.8M | Buy |
383,677
+20,690
| +6% | +$590K | 0.53% | 67 |
|
|
2014
Q1 | $11.1M | Buy |
362,987
+13,163
| +4% | +$392K | 0.57% | 60 |
|
|
2013
Q4 | $10.2M | Buy |
349,824
+3,950
| +1% | +$115K | 0.54% | 61 |
|
|
2013
Q3 | $9.43M | Buy |
345,874
+7,203
| +2% | +$196K | 0.55% | 60 |
|
|
2013
Q2 | $9M | Buy |
+338,671
| New | +$9.36M | 0.56% | 60 |
|
Other funds holding PFE
Bradley Foster & Sargent's PFE Position: Q2 2026 in Review
Bradley Foster & Sargent increased its Pfizer (PFE) stake by 10% in Q2 2026, buying an estimated $1.68M and bringing the position to 678,377 shares worth $16.3M. The position accounts for 0.23% of the portfolio, ranked #94.
Bradley Foster & Sargent first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.5M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Bradley Foster & Sargent held 678,377 shares of Pfizer worth $16.3M as of Q2 2026.
- Bradley Foster & Sargent bought 64,360 Pfizer shares in Q2 2026, an estimated $1.68M.
- Pfizer made up 0.23% of Bradley Foster & Sargent's portfolio in Q2 2026, its #94 holding.
- Bradley Foster & Sargent first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Bradley Foster & Sargent's Pfizer position peaked at $18.5M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.